
Augme
closedStrategic services and mobile technology for consumer and healthcare brands.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
Total Funding | 000k |
No items found
No investors found
USD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 17 % | 34 % | 40 % | 45 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (104 %) | (83 %) | (81 %) | (72 %) | (35 %) |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (131 %) | (95 %) | (81 %) | (79 %) | (43 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 49 % | 27 % | 30 % | 33 % | 25 % |
Source: Company filings or news article